Newsroom
Your source for Evernorth news.
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Estimated to save individual Accredo patients around $4,000 per year
Biosimilar price will be more than 80% lower than Stelara list price
Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (50)
Press Release
Evernorth Health Services, the NBA and WNBA announce new multi-year partnership to improve community health and vitality
February 05, 2025
• Evernorth named the official health services partner of the NBA and WNBA
• Partnership launches fan-facing NBA Total Health platform
Press Release
Evernorth Announces New Cost and Transparency Protections for its Express Scripts Patients
January 29, 2025
• Actions aim to lower patient out-of-pocket costs
• Expands transparency for both patients and those who provide their benefits
Press Release
Express Scripts Comments on FTC’s Reckless Insulin Action
September 20, 2024
Press Release
Express Scripts Sues FTC, Demands Withdrawal of PBM Report
September 17, 2024
Press Release
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early May
September 05, 2024